FBO#5333
B - Special Studies and Analyses - Not R&D
FEDBIZOPPS: AWARDS - June 30, 2016
- SeeBelow - Maximum IDIQ ceiling $9,900,000
PRECLINICAL PHARMACOKINETIC AND PHARMACOLOGY EVALUATIONS OF AGENTS BEING DEVELOPED FOR CANCER PATIENTS
See Description
| This Issue's Index | Today's FBO Daily Index Page |
Created on 28-Jun-2016 by Loren Data Corp. -- info@fbodaily.com